Inspire Medical Systems Launches Inspire V for OSA

Inspire Medical Systems ( (INSP) ) has shared an announcement.

Inspire Medical Systems announced the full launch of Inspire V in May 2025, highlighting its advanced accelerometer-based sensing technology for treating obstructive sleep apnea (OSA). This innovation simplifies the implant procedure and enhances therapy effectiveness by accurately timing stimulation during the most vulnerable phases of the breathing cycle, potentially improving patient outcomes and reducing the need for revisions.

The most recent analyst rating on (INSP) stock is a Hold with a $170.00 price target. To see the full list of analyst forecasts on Inspire Medical Systems stock, see the INSP Stock Forecast page.

Spark’s Take on INSP Stock

According to Spark, TipRanks’ AI Analyst, INSP is a Outperform.

Inspire Medical Systems presents a strong financial performance and positive earnings call outlook, driving the overall score. However, technical analysis indicates bearish momentum, and valuation metrics suggest the stock may be overvalued, slightly dampening the overall score.

To see Spark’s full report on INSP stock, click here.

More about Inspire Medical Systems

Inspire Medical Systems, Inc. is a medical technology company focused on enhancing patient lives through innovative sleep solutions. The company is committed to operational excellence, therapy adoption, and strengthening organizational culture, with a focus on outcomes and integrity.

Average Trading Volume: 488,585

Technical Sentiment Signal: Sell

Current Market Cap: $3.91B

For an in-depth examination of INSP stock, go to TipRanks’ Overview page.